Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Morphic Therapeutic logo — Wholly owned subsidiary of Eli Lilly and Company

Morphic Therapeutic

Wholly owned subsidiary of Eli Lilly and Company

Founded 2015 United States Waltham, United States 128 employees Post-IPO Equity Biotechnology, Health Care +1

General Information

Company Name Morphic Therapeutic
Founded Year 2015
Location United States Waltham, United States
Employees 128
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Morphic Therapeutic. To contact Morphic Therapeutic, visit morphictx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Morphic Therapeutic compare?

A PDF of Morphic Therapeutic and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Morphic Therapeutic soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Morphic Therapeutic

Oral integrin therapies for patients with immunological, fibrotic, neoplastic and vascular diseases. Morphic Tx is joining a three decade quest led by our scientific founder, Tim Springer, who initially discovered the integrin receptor family in the 1980s. This receptor family is an important drug target that has fueled the successful development of six injectable therapies approved for treatment of multiple sclerosis, ulcerative colitis, Crohn's disease, plaque psoriasis, acute coronary syndrome and complications during percutaneous coronary intervention. Despite blockbuster commercial success, integrins have remained out of reach as small molecule drugs...until now.

No funding data available for Morphic Therapeutic yet.

FAQ About Morphic Therapeutic

Wholly owned subsidiary of Eli Lilly and Company
Morphic Therapeutic was founded in 2015.
Morphic Therapeutic is headquartered in Waltham, United States.
Morphic Therapeutic operates in Biotechnology, Health Care and Health and Wellness.
Morphic Therapeutic has approximately 128 employees.

We're actively collecting intelligence on Morphic Therapeutic.

Source: BounceWatch company record for Morphic Therapeutic, https://bouncewatch.com/company/morphic-therapeutic, updated 7 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes